Title : Utilizing computerized cognitive testing in neurology practices
Abstract:
Research increasingly supports the concept that cognition should be considered the 5th Vital Sign, highlighting the critical importance for neurological practices to measure cognitive functioning routinely. Early diagnosis of cognitive disorders and cognitive dysfunctions is a major healthcare priority, offering significant benefits to patients, medical providers, and families. Accurate and timely detection can lead to better management and intervention strategies, potentially improving patient outcomes and quality of life.
This presentation will explore the pros and cons of computerized testing versus traditional cognitive screening measures such as the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Kokmen Short Test of Mental Status. The advantages of computerized cognitive assessments include increased sensitivity, consistency in administration, and the ability to capture subtle changes over time. In contrast, traditional methods, while well-established and widely recognized, may be limited by subjective interpretation and variability in administration.
Brief self-administered computerized cognitive tools hold substantial promise for clinical implementation. They can significantly reduce staff time, streamline workflow, and improve financial productivity by utilizing appropriate billing codes in the United States. This can be particularly advantageous in busy neurology practices where efficiency and accuracy are paramount.
Several key computerized testing platforms will be reviewed, including the Computer-Administered Neuropsychological Screen for Mild Cognitive Impairment (CAMCI), Cognitive Assessment and Neurocognitive Screening-Mild Cognitive Impairment (CANS-MCI), CNS Vital Signs (CNSVS), CogState, Cognitive Tool for Objective Cognitive Evaluation (C-TOC), and electronic Self-Administered Gerocognitive Examination (eSAGE). Each of these tools offers unique features and benefits, catering to different aspects of cognitive assessment.
Practical examples of how to integrate these computerized testing tools into a neurology practice will be provided. This includes considerations for initial setup, training of staff, patient education, and interpreting results within the clinical context. Participants will leave the discussion equipped with the knowledge and confidence to leverage digital technologies for cognitive assessment, ultimately enhancing the care provided in their neurology practices.
Audience Take Away Notes:
- Learn pros and cons of traditional versus computerized cognitive screens
- Understand practical examples of how computerized testing can be used in a neurology practice
- Understand benefits of computerized testing for patients, families, and clinical practice
